| ID Source | ID |
|---|---|
| PubMed CID | 28935 |
| CHEMBL ID | 2106359 |
| CHEBI ID | 82136 |
| SCHEMBL ID | 39677 |
| MeSH ID | M0042392 |
| Synonym |
|---|
| nsc-190998 |
| nuvanol n |
| o,o-dimethyl-o-2,5-dichloro-4-iodophenyl thiophosphate |
| nsc 190998 |
| ciba c-9491 |
| iodofenphos |
| o-(2,5-dichloro-4-iodophenyl) o,o-dimethyl phosphorothioate |
| jodfenphos [iso] |
| iodofenphos [ban] |
| oms-1211 |
| o,o-dimethyl-o-(2,5-dichlor-4-jodphenyl)-monothiophosphat [german] |
| epa pesticide chemical code 309700 |
| jodfenphos |
| iodofenphos [bsi:iso] |
| iodophos |
| o-(2,5-dichloro-4-iodophenyl)-o,o-dimethyl phosphorothioate |
| hsdb 1568 |
| ai3-27408 |
| c 9491 |
| iodofenfos |
| o,o-dimethyl-o-(2,5-dichlor-4-jodphenyl)-thionophosphat [german] |
| ent 27408 |
| caswell no. 309b |
| compound c-9491 |
| trix |
| monocron 9491 |
| iodophenphos |
| brn 1885795 |
| phenol, 3,4-dichloro-, o-ester with o-methyl methylphosphoramidothioate |
| ciba-geigy c-9491 |
| c-9491 |
| einecs 242-069-1 |
| alfacron |
| phosphorothioic acid, o-(2,5-dichloro-4-iodophenyl) o,o-dimethyl ester |
| NCGC00248206-01 |
| C19002 |
| 18181-70-9 |
| sme6g1846x , |
| o,o-dimethyl-o-(2,5-dichlor-4-jodphenyl)-thionophosphat |
| unii-sme6g1846x |
| o,o-dimethyl-o-(2,5-dichlor-4-jodphenyl)-monothiophosphat |
| dtxsid8040278 , |
| cas-18181-70-9 |
| dtxcid6020278 |
| NCGC00254814-01 |
| tox21_300910 |
| iodenphos |
| AKOS015903240 |
| iodofenphos [mart.] |
| iodofenphos [hsdb] |
| iodofenphos [mi] |
| chebi:82136 , |
| CHEMBL2106359 |
| SCHEMBL39677 |
| iodfenphos |
| o,o-dimethyl o-(2,5-dichloro-4-iodophenyl) phosphorothioate |
| o-(2,5-dichloro-4-iodophenyl) o,o-dimethyl thiophosphate # |
| ciba c 9491 |
| LFVLUOAHQIVABZ-UHFFFAOYSA-N |
| elocril |
| oms 1211 |
| iodofenophos |
| ciba 9491 |
| sr-01000883722 |
| SR-01000883722-1 |
| jodfenphos, pestanal(r), analytical standard |
| iodofenphos 100 microg/ml in cyclohexane |
| J-011634 |
| Q27155764 |
| (2,5-dichloro-4-iodophenoxy)-dimethoxy-sulfanylidene-lambda5-phosphane |
| iodofenphos 1000 microg/ml in acetone |
| Class | Description |
|---|---|
| organic thiophosphate | |
| [compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res] | |
| Protein | Taxonomy | Measurement | Average (µ) | Min (ref.) | Avg (ref.) | Max (ref.) | Bioassay(s) |
|---|---|---|---|---|---|---|---|
| Luciferase | Photinus pyralis (common eastern firefly) | Potency | 79.6407 | 0.0072 | 15.7588 | 89.3584 | AID1224835 |
| acetylcholinesterase | Homo sapiens (human) | Potency | 31.7055 | 0.0025 | 41.7960 | 15,848.9004 | AID1347398 |
| RAR-related orphan receptor gamma | Mus musculus (house mouse) | Potency | 48.5577 | 0.0060 | 38.0041 | 19,952.5996 | AID1159523 |
| GLI family zinc finger 3 | Homo sapiens (human) | Potency | 38.5708 | 0.0007 | 14.5928 | 83.7951 | AID1259369; AID1259392 |
| AR protein | Homo sapiens (human) | Potency | 48.5850 | 0.0002 | 21.2231 | 8,912.5098 | AID1259243; AID1259247; AID743035; AID743036; AID743063 |
| estrogen receptor 2 (ER beta) | Homo sapiens (human) | Potency | 24.3365 | 0.0006 | 57.9133 | 22,387.1992 | AID1259378 |
| nuclear receptor subfamily 1, group I, member 3 | Homo sapiens (human) | Potency | 20.0391 | 0.0010 | 22.6508 | 76.6163 | AID1224838; AID1224839; AID1224893 |
| progesterone receptor | Homo sapiens (human) | Potency | 35.1238 | 0.0004 | 17.9460 | 75.1148 | AID1346784; AID1346795 |
| glucocorticoid receptor [Homo sapiens] | Homo sapiens (human) | Potency | 24.5412 | 0.0002 | 14.3764 | 60.0339 | AID720692 |
| estrogen-related nuclear receptor alpha | Homo sapiens (human) | Potency | 54.8284 | 0.0015 | 30.6073 | 15,848.9004 | AID1224848; AID1224849; AID1259403 |
| estrogen nuclear receptor alpha | Homo sapiens (human) | Potency | 41.4716 | 0.0002 | 29.3054 | 16,493.5996 | AID743069; AID743075; AID743077 |
| peroxisome proliferator activated receptor gamma | Homo sapiens (human) | Potency | 40.2041 | 0.0010 | 19.4141 | 70.9645 | AID743140; AID743191 |
| aryl hydrocarbon receptor | Homo sapiens (human) | Potency | 17.8162 | 0.0007 | 23.0674 | 1,258.9301 | AID743085; AID743122 |
| v-jun sarcoma virus 17 oncogene homolog (avian) | Homo sapiens (human) | Potency | 16.6317 | 0.0578 | 21.1097 | 61.2679 | AID1159526; AID1159528 |
| thyroid hormone receptor beta isoform 2 | Rattus norvegicus (Norway rat) | Potency | 68.5896 | 0.0003 | 23.4451 | 159.6830 | AID743065; AID743067 |
| heat shock protein beta-1 | Homo sapiens (human) | Potency | 3.0896 | 0.0420 | 27.3789 | 61.6448 | AID743210 |
| nuclear factor erythroid 2-related factor 2 isoform 1 | Homo sapiens (human) | Potency | 68.5896 | 0.0006 | 27.2152 | 1,122.0200 | AID743202 |
| Cellular tumor antigen p53 | Homo sapiens (human) | Potency | 63.5690 | 0.0023 | 19.5956 | 74.0614 | AID651631; AID720552 |
| [prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023] | |||||||
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 3 (50.00) | 18.7374 |
| 1990's | 3 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.
| This Compound (19.88) All Compounds (24.57) |
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 0 (0.00%) | 6.00% |
| Case Studies | 1 (12.50%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 7 (87.50%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||